145 related articles for article (PubMed ID: 2533741)
1. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease].
Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A; Ahmadi R
Vasa Suppl; 1989; 27():244-6. PubMed ID: 2533741
[No Abstract] [Full Text] [Related]
2. Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease.
Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A
Thromb Res; 1988 Nov; 52(3):219-26. PubMed ID: 2973666
[TBL] [Abstract][Full Text] [Related]
3. Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease.
Minar E; Ehringer H
Thromb Res; 1987 Mar; 45(6):791-802. PubMed ID: 2954264
[TBL] [Abstract][Full Text] [Related]
4. Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease.
Minar E; Ehringer H; Schöfl R
Klin Wochenschr; 1987 May; 65(9):419-23. PubMed ID: 2955158
[TBL] [Abstract][Full Text] [Related]
5. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F
J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of platelet survival time measurements in patients with peripheral arterial occlusive disease.
Minar E; Ehringer H
Thromb Res; 1987 Oct; 48(1):73-9. PubMed ID: 2962335
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease.
Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL
J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468
[TBL] [Abstract][Full Text] [Related]
8. Platelet alpha granule secretion in cerebral ischemia: effect of short and long term low dose aspirin treatment.
D'Andrea G; Joseph R; Cananzi AR; Ferro-Milone F; Grunfeld S; Toldo M; Welch MA
Funct Neurol; 1988; 3(2):179-85. PubMed ID: 2456969
[TBL] [Abstract][Full Text] [Related]
9. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
Al-Mondhiry H; Pierce WS; Pennock JL
J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
[TBL] [Abstract][Full Text] [Related]
10. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
11. Platelet factor 4 and beta thromboglobulin in Moya-Moya disease.
Albala MM; Levine PH
Am J Pediatr Hematol Oncol; 1984; 6(1):96-9. PubMed ID: 6201080
[TBL] [Abstract][Full Text] [Related]
12. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
14. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
15. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
16. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet damage in two different centrifugal pumps based on measurements of alpha-granule packing proteins.
Mohara J; Kawahito K; Misawa Y; Fuse K
Artif Organs; 1998 May; 22(5):371-4. PubMed ID: 9609343
[TBL] [Abstract][Full Text] [Related]
18. [Platelet function in tension headache].
Leira R; Castillo J; Castro A; Rodríguez JR; Lema M; Noya M
Neurologia; 1990 Mar; 5(3):78-81. PubMed ID: 2141791
[TBL] [Abstract][Full Text] [Related]
19. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445
[No Abstract] [Full Text] [Related]
20. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
